---
title: "Medtronic PLC Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296398517.md"
description: "Medtronic PLC (MDT) shares rose 2.22% to $94.13 on Wednesday, outperforming the broader market's modest gains. This marks the stock's second consecutive day of increases, though it remains 11.47% below its 52-week high. While Medtronic gained, competitors like Danaher Corp. saw larger percentage rises. Trading volume was lower than the 50-day average."
datetime: "2026-08-19T20:38:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296398517.md)
  - [en](https://longbridge.com/en/news/296398517.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296398517.md)
generator: "portal-rs"
---

# Medtronic PLC Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Medtronic PLC (MDT) rose 2.22% to $94.13 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.21% to 7,707.98 and the Dow Jones Industrial Average rising 0.22% to 53,463.05.

This was the stock's second consecutive day of gains.

Medtronic PLC closed 11.47% below its 52-week high of $106.33, which the company reached on November 26th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 0.85% to $273.41, Danaher Corp. (DHR) rose 5.97% to $211.50, and Abbott Laboratories (ABT) rose 1.55% to $114.43.

Trading volume (5.6 M) remained 2.5 million below its 50-day average volume of 8.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 19, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-19-26 1638ET

### Related Stocks

- [MDT.US](https://longbridge.com/en/quote/MDT.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [DHR.US](https://longbridge.com/en/quote/DHR.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Analyst Brandon Vazquez Reaffirms Buy on Medtronic, Citing Strong FY2027 Outlook and Attractive Risk‑Reward Profile](https://longbridge.com/en/news/298641077.md)
- [Orchestra BioMed highlights $500 million-plus annual royalty potential from Medtronic-partnered AVIM pacemaker therapy](https://longbridge.com/en/news/298326982.md)
- [Medtronic Analysts Raise Their Forecasts After Upbeat Q1 Earnings](https://longbridge.com/en/news/297780375.md)
- [Medtronic’s Stars Are Aligning for a Price Recovery](https://longbridge.com/en/news/297677128.md)
- [22:45 ETCornerstone Robotics ogłasza strategiczne partnerstwo z Medtronic mające na celu zwiększenie dostępu do chirurgii robotycznej na świecie](https://longbridge.com/en/news/297724147.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**